Commitments and Contingencies (Details) - USD ($) $ in Millions |
1 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 15, 2012 |
Dec. 31, 2023 |
|
| Commitments and Contingencies [Abstract] | ||
| Milestone payment | $ 1 | |
| Description of royalty payment | Upon commercial sale of the drug, royalty payments of 2% of net sales will be due to FHCRC. | |
| Net sales | 2.00% |
| X | ||||||||||
- Definition Description of royalty payment to related party. No definition available.
|
| X | ||||||||||
- Definition The amount of milestone payment. No definition available.
|
| X | ||||||||||
- Definition Net sales. No definition available.
|
| X | ||||||||||
- References No definition available.
|